G. V. R. Born

Medicine · Health Sciences

40h-index11.8kcitations164works2.02yr avg
OpenAlex↗Google Scholar↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Antiplatelet Therapy and Cardiovascular Diseases(29), Platelet Disorders and Treatments(22), Blood properties and coagulation(20), Nitric Oxide and Endothelin Effects(9), Analytical Methods in Pharmaceuticals(9)

Publications164 total

As though the ’80s never happened – recalibrating value through music
Journal of the British Academy·2024· 2 citedOpen Access
Platelet Pharmacology in Relation to Thrombosis
Advances in cardiology·2015· 8 cited
Comprar Antiplatelet Agents | Paolo Gresele | 9783642294228 | Springer
2012
A classic collaboration: Michael Davies on plaque vulnerability
Atherosclerosis·2011· 4 cited
The role of vascular myoglobin in nitrite-mediated blood vessel relaxation
Cardiovascular Research·2010· 60 citedOpen Access
Kenneth Walter William Henry Walton
BMJ·2009
Análisis de sobrevida del cáncer gástrico en anillo de sello según profundidad y compromiso linfonodal* Survival of patients with signet ring cell carcinoma of the stomach, compared with patients with non ring cell gastric cáncer
2008
Light on platelets
The Journal of Physiology·2005· 10 citedOpen Access
Handbook of experimental pharmacology
2002· 115 cited
Effects of reserpine on expression of the LDL receptor in liver and on plasma and tissue lipids, low density lipoprotein and fibrinogen in rabbits in vivo
Atherosclerosis·2000· 5 cited
[Factors affecting the trans-endothelial accumulation of atherogenic plasma proteins in artery walls].
PubMed·1998
Experiments on the risk factor role of fibrinogen
Fibrinolysis & proteolysis/Fibrinolysis and proteolysis·1997
Effect of Captopril and Losartan on Blood Pressure and Accumulation of LDL and Fibrinogen by Aortic Wall and Other Tissues in Normotensive and Hypertensive Rats
Journal of Cardiovascular Pharmacology·1997· 10 cited
[Arteriohepatic dysplasia (Alagille syndrome). A case report].
PubMed·1996
4. Fibrinogen: how to explain its risk factor status
Fibrinolysis and Proteolysis·1996
Increase by adrenaline or angiotensin II of the accumulation of low density lipoprotein and fibrinogen by aortic walls in unrestrained conscious rats
British Journal of Pharmacology·1996· 14 citedOpen Access
Effect of inhibition of nitric oxide synthesis on the uptake of LDL and fibrinogen by arterial walls and other organs of the rat
British Journal of Pharmacology·1995· 51 citedOpen Access
Inhibition by Nifedipine of the Efflux of Plasma Low-Density Lipoprotein and Albumin from the Vasculature of the Mouse Mesentery in Vivo
Microvascular Research·1995· 5 cited
Determinants of LDL and fibrinogen uptake by artery walls
Atherosclerosis·1994
Effect of increasing doses of angiotensin II infused into normal and hypertensive Wistar rats on low density lipoprotein and fibrinogen uptake by aortic walls.
Proceedings of the National Academy of Sciences·1994· 20 citedOpen Access
page 1 of 9Next →

Frequent Co-authors

P. D. Richardson(5), Michael Cross(4), G. S. Dawes(4), Nicola A. Begent(3), Joan C. Mott(3), Corinne Lendon(2), M.A.A. Kratzer(2), F Michal(2), Harold Feinberg(2), Michael J. Davies(2), David E. Sharp(2), P. Görög(2), Melanie J. Davies(1), Hans R. Baumgartner(1), Michael Hume(1), Barbara R. Rennick(1), Richard J. Haslam(1), MIRYAM GOLDMAN(1), Robert Lowe(1), D. BERGQUIST(1)